ACE appoints David Colpman to board
This article was originally published in Scrip
Executive Summary
ACE BioSciences (Denmark), a company developing vaccines to protect against infectious diseases caused by bacteria, has elected Shire's senior vice-president of business development, David Colpman, to its board.